Risk of serious adverse effects ofbiological and targeted drugs in patients with rheumatoid arthritis: asystematic review meta-analysis. Tarp S, Furst E, et al. Rheumatology (Oxford). 2017 Mar1;56(3):417-425. https://www.ncbi.nlm.nih.gov/p…